DOPAFUSE

Serial Number 88418888
Registration 6389896
700

Registration Progress

Application Filed
May 7, 2019
Under Examination
Oct 29, 2019
Approved for Publication
Sep 3, 2019
Published for Opposition
Sep 3, 2019
Registered
Jun 15, 2021

Trademark Image

DOPAFUSE

Basic Information

Serial Number
88418888
Registration Number
6389896
Filing Date
May 7, 2019
Registration Date
June 15, 2021
Published for Opposition
September 3, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 15, 2021
Registration
Registered
Classes
005

Rights Holder

SynAgile Corporation

03
Address
Suite 104, PMB 218
3465 N. Pines Way
Wilson, WY 83014

Ownership History

SynAgile Corporation

Original Applicant
03
Wilson, WY

SynAgile Corporation

Owner at Publication
03
Wilson, WY

SynAgile Corporation

Original Registrant
03
Wilson, WY

Legal Representation

Attorney
Jeffrey J. Ellison

USPTO Deadlines

Next Deadline
513 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210615)
Due Date
June 15, 2027
Grace Period Ends
December 15, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Jun 15, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 13, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 12, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 23, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 22, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 7, 2021 IUAF S USE AMENDMENT FILED Loading...
Apr 22, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 7, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 21, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 7, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 7, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 23, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 21, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 21, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 21, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 23, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 21, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 21, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 21, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 29, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 3, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 3, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 14, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 22, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 22, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
May 22, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 10, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for the treatment of neurological disorders, namely, Parkinson's Disease
First Use Anywhere: Mar 30, 2021
First Use in Commerce: Mar 30, 2021

Additional Information

Pseudo Mark
DOPA FUSE

Classification

International Classes
005